Concepedia

Sergey Grishin

SG

3

Publications

119

Citations

3

H-Index

2022

Active since

Affiliations

R-Pharm (Russia)(Current)

Medical University of Vienna

Metroplex Clinical Research Center

The University of Texas Southwestern Medical Center

Sergey Grishin is an author at R-Pharm (Russia).

Publications per year

2022–2024

3

Publications

3

Olokizumab versus Placebo or Adalimumab in Rheumatoid Arthritis

Josef S Smolen, Eugen Feist, Saeed Fatenejad et al. · New England Journal of Medicine · 2022 · 70 citations · Full text

Olokizumab, a monoclonal antibody against interleukin-6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by tumour necrosis factor inhibitor therapy: efficacy and safety results of a randomised controlled phase III study

Eugen Feist, Saeed Fatenejad, Sergey Grishin et al. · Annals of the Rheumatic Diseases · 2022 · 38 citations · Full text

Interleukin-1 Blockade With RPH-104 (Goflikicept) in Patients With ST-Segment Elevation Myocardial Infarction: Secondary End Points From an International, Double-Blind, Randomized, Placebo-Controlled, Phase 2a Study

Antonio Abbate, Benjamín Van Tassell, Vladimir Bogin et al. · Journal of Cardiovascular Pharmacology · 2024 · 11 citations · Full text

Rows per page

1–3 of 3